Back

Maternal fluconazole use during the third trimester and risk of QT prolongation in the offspring

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Cardiotoxicity and protection: from bench to bedside Cardiotoxicity of Drugs ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Giaan Ninh

Herlev Hospital, Herlev (Denmark)

6 More presentations in this session

Presentation thumbnail
Real-world health status changes with mavacamten in symptomatic obstructive hypertrophic cardiomyopathy (oHCM) - Early findings from COMPASS-HCM
Professor A. Wang (Durham, US)
Abstract Slides Video
Presentation thumbnail
A UK multicentre experience of osimertinib related cardiovascular toxicity: real world patterns, risk stratification and surveillance
Doctor C. Simela (Leeds, GB)
Abstract Slides Video
Presentation thumbnail
Impact of dapagliflozin on cardiac remodeling and sirtuin expression in rats with type 1 diabetes mellitus
Associate Professor M. Okoshi (Botucatu, BR) Miss A. Marreiros (Botucatu, BR)
Abstract Slides Video
Presentation thumbnail
Ranolazine ameliorates palmitic acid-induced insulin resistance in HL-1 cardiomyocytes by Ca2+/ CaMKII modulation: an in vitro investigation and population-based cohort study
Professor P. Liu (Tainan, TW)
Abstract Slides Video
Presentation thumbnail
Safety and efficacy of migalastat in Fabry's disease treatment with cardiac impact : a systematic review and meta-analysis
Mr L. Oldra (Sao Paulo, BR)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiotoxicity and protection: from bench to bedside

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Maternal medication use patterns during the periconceptional period and risk of congenital heart defects: A nationwide register-based cohort study
thumbnail
Congress Presentation
Electrocardiographic findings in newborns with inadequate intrauterine growth during pregnancy
thumbnail
Congress Presentation
Maternal and fetal outcomes of various lipid-lowering treatment regimens during pregnancy: insights from the czech national registry 2012-2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources